| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
61,702 |
51,776 |
$2.81M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,949 |
17,732 |
$671K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,958 |
26,552 |
$184K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,383 |
2,302 |
$165K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,907 |
7,434 |
$159K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,369 |
2,089 |
$145K |
| 99072 |
|
29,443 |
24,629 |
$66K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
980 |
963 |
$66K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,561 |
5,365 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,398 |
4,232 |
$60K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,966 |
3,640 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
13,902 |
12,147 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,390 |
1,145 |
$32K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
417 |
410 |
$32K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
519 |
496 |
$26K |
| 99051 |
|
7,228 |
6,693 |
$22K |
| 87081 |
|
3,421 |
3,304 |
$21K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
498 |
451 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
757 |
697 |
$19K |
| 36416 |
|
22,844 |
21,073 |
$19K |
| 99460 |
|
309 |
301 |
$14K |
| 99219 |
|
136 |
131 |
$11K |
| 99172 |
|
839 |
826 |
$10K |
| 92583 |
|
435 |
414 |
$10K |
| 81001 |
|
4,644 |
4,288 |
$9K |
| 95117 |
|
688 |
258 |
$9K |
| 99223 |
Prolong inpt eval add15 m |
71 |
67 |
$8K |
| 99220 |
|
53 |
52 |
$6K |
| 99217 |
|
116 |
108 |
$6K |
| 99235 |
|
40 |
40 |
$5K |
| 54150 |
|
67 |
66 |
$5K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
518 |
375 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
51 |
48 |
$4K |
| 92552 |
|
350 |
330 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
60 |
45 |
$3K |
| 99462 |
|
123 |
107 |
$3K |
| 95115 |
|
261 |
101 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
53 |
48 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
99 |
96 |
$2K |
| 90633 |
|
893 |
872 |
$2K |
| 90688 |
|
127 |
116 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
24 |
$2K |
| 90670 |
|
1,214 |
1,170 |
$1K |
| 90686 |
|
489 |
478 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,293 |
1,996 |
$1K |
| 80053 |
Comprehensive metabolic panel |
533 |
473 |
$996.39 |
| 90648 |
|
881 |
875 |
$957.83 |
| 80061 |
Lipid panel |
680 |
606 |
$880.56 |
| 99381 |
|
12 |
12 |
$864.38 |
| 99406 |
|
160 |
152 |
$747.36 |
| 90723 |
|
531 |
528 |
$688.10 |
| 90680 |
|
782 |
762 |
$575.58 |
| 90734 |
|
215 |
211 |
$485.41 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
130 |
118 |
$485.41 |
| 90716 |
|
287 |
282 |
$456.94 |
| 99490 |
Ccm add 20min |
111 |
91 |
$404.56 |
| 90707 |
|
290 |
285 |
$382.14 |
| 90671 |
|
357 |
355 |
$307.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
24 |
$290.94 |
| 90715 |
|
118 |
112 |
$198.93 |
| 90700 |
|
60 |
56 |
$182.10 |
| 99188 |
|
15 |
15 |
$168.75 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27 |
26 |
$94.95 |
| 90651 |
|
145 |
141 |
$88.90 |
| 90619 |
|
20 |
20 |
$82.00 |
| 90696 |
|
57 |
57 |
$73.60 |
| 86308 |
|
14 |
12 |
$66.78 |
| 90697 |
|
399 |
375 |
$36.27 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,071 |
1,802 |
$36.24 |
| 888888 |
|
1,354 |
1,207 |
$30.00 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
141 |
132 |
$25.16 |
| 3078F |
|
18,585 |
16,268 |
$24.86 |
| 3074F |
|
17,985 |
15,791 |
$23.86 |
| 3077F |
|
2,313 |
1,999 |
$21.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
24 |
$11.99 |
| 3079F |
|
3,156 |
2,793 |
$8.05 |
| 3075F |
|
2,628 |
2,372 |
$6.76 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
35 |
24 |
$2.34 |
| 3080F |
|
740 |
646 |
$2.04 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,788 |
1,719 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
2,303 |
1,878 |
$0.00 |
| 3008F |
|
2,029 |
1,907 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
273 |
269 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
89 |
87 |
$0.00 |
| G9783 |
Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy |
17 |
16 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,767 |
4,346 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,157 |
2,995 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,810 |
1,585 |
$0.00 |
| 1160F |
|
1,606 |
1,465 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
257 |
236 |
$0.00 |
| 4013F |
|
190 |
164 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
217 |
209 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| G9509 |
Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 |
47 |
44 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
15 |
14 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
56 |
47 |
$0.00 |
| 0124A |
|
15 |
12 |
$0.00 |